Torrent Pharmaceuticals Limited has informed the Exchange that Board of Directors at its meeting held on February 13, 2026, declared Interim Dividend of Rs. 29 per equity share.
TORNTPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.8 pts more than Nifty 100 and 5.2 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Torrent Pharmaceuticals' Board, at its meeting on February 13, 2026, declared an interim dividend of Rs. 29 per equity share (580%) on shares with a face value of Rs. 5 each. The dividend is expected to be paid or dispatched on or around March 6, 2026. The announcement also coincides with the company's Q3 FY26 results: consolidated revenue of Rs. 3,303 crore (up 18% year-on-year) and net profit of Rs. 635 crore (up 26% year-on-year). The nine-month FY26 net profit stood at Rs. 1,774 crore, up 26% from the prior year period. The company also completed the acquisition of a 48.8% controlling stake in J.B. Chemicals & Pharmaceuticals, making Torrent the 5th largest player in the Indian pharma market post-merger.
Shareholders will receive a meaningful interim payout, signalling confidence in cash generation despite the recent JB Pharma acquisition. The strong Q3 earnings growth and completed acquisition could support the stock, though the merger is still pending SEBI and NCLT approvals which may keep near-term sentiment mixed.